Expected Alzheimer’s drug approval signals new era in treatment ...Middle East

The Food and Drug Administration’s expected approval of Biogen and Eisai’s Alzheimer’s drug Leqembi, or lecanemab, is set to broaden access and accelerate a new class of treatments for the degenerative disease. A number of patient advocacy groups are eagerly awaiting the decision, which would trigger broader access under Medicare. But the drug still faces […] The post Expected Alzheimer’s drug approval signals new era in treatment appeared first on Roll Call.

Read More Details
Finally We wish PressBee provided you with enough information of ( Expected Alzheimer’s drug approval signals new era in treatment )

Also on site :

• On the record: Hubbard
• ForexLive Asia-Pacific FX news wrap: Oil spike on talk of Israel preparing attack on Iran
• CNN Confession: Jake Tapper Admits Conservative Media Was Right About Biden’s Cognitive Decline